Gene · 7272
Papers3,094
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,094
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chromosome segregation: Mps1 and Dam1 battle to bind a shared interaction site at the kinetochore. | Curr Biol | 2024 | 38834024 | PubTator, text mining | PubMed |
| Hijacking monopolar spindle 1 (MPS1) for various cancer types by small molecular inhibitors: Deep insights from a decade of research and patents. | Eur J Med Chem | 2024 | 38795520 | PubTator, text mining | PubMed |
| Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation. | BMC Complement Med Ther | 2024 | 38783288 | PubTator, text mining | PubMed |
| Metabolic pathway-based subtypes associate glycan biosynthesis and treatment response in head and neck cancer. | NPJ Precis Oncol | 2024 | 38783045 | PubTator, text mining | PubMed |
| FBXO42 activity is required to prevent mitotic arrest, spindle assembly checkpoint activation and lethality in glioblastoma and other cancers. | NAR Cancer | 2024 | 38774470 | PubTator, text mining | PubMed |
| Immune profiling of dedifferentiated liposarcoma and identification of novel antigens for targeted immunotherapy. | Sci Rep | 2024 | 38755218 | PubTator, text mining | PubMed |
| Machine learning and multi-omics data reveal driver gene-based molecular subtypes in hepatocellular carcinoma for precision treatment. | PLoS Comput Biol | 2024 | 38728362 | PubTator, text mining | PubMed |
| Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment. | Cancer Rep (Hoboken) | 2024 | 38717954 | PubTator, text mining | PubMed |
| Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. | Mol Cancer | 2024 | 38711083 | PubTator, text mining | PubMed |
| LINC01572 promotes the malignant progression of lung adenocarcinoma by modulating p53 mediated by miRNA-338-5p/TTK axis. | J Pharm Pharmacol | 2024 | 38698658 | PubTator, text mining | PubMed |
| Validation of Core Ingredients and Molecular Mechanism of Cinobufotalin Injection Against Liver Cancer. | Drug Des Devel Ther | 2024 | 38681206 | PubTator, text mining | PubMed |
| Annexin A2 combined with TTK accelerates esophageal cancer progression via the Akt/mTOR signaling pathway. | Cell Death Dis | 2024 | 38658569 | PubTator, text mining | PubMed |
| New treatment alternatives for primary and metastatic colorectal cancer by an integrated transcriptome and network analyses. | Sci Rep | 2024 | 38627442 | PubTator, text mining | PubMed |
| Simvastatin activates the spindle assembly checkpoint and causes abnormal cell division by modifying small GTPases. | Cell Signal | 2024 | 38604342 | PubTator, text mining | PubMed |
| Expression of circular RNA has-circ-0009158 and identification of associated miRNA-mRNA network in hepatocellular carcinoma. | Am J Transl Res | 2024 | 38463586 | PubTator, text mining | PubMed |
| Differential anti-viral response to respiratory syncytial virus A in preterm and term infants. | EBioMedicine | 2024 | 38447274 | PubTator, text mining | PubMed |
| Identification of a lncRNA/circRNA-miRNA-mRNA network in Nasopharyngeal Carcinoma by deep sequencing and bioinformatics analysis. | J Cancer | 2024 | 38434987 | PubTator, text mining | PubMed |
| Regulation and tumor-suppressive function of the miR-379/miR-656 (C14MC) cluster in cervical cancer. | Mol Oncol | 2024 | 38400534 | PubTator, text mining | PubMed |
| Real-time monitoring polymerization degree of organic photovoltaic materials toward no batch-to-batch variations in device performance. | Nat Commun | 2024 | 38341407 | PubTator, text mining | PubMed |
| CCNB1 may as a biomarker for the adipogenic differentiation of adipose-derived stem cells in the postoperative fat transplantation of breast cancer. | Gland Surg | 2024 | 38323233 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7272/papers?page=11